|
Volumn 88, Issue 37, 2008, Pages 2629-2632
|
Influence of preoperative chemoradiotherapy, preoperative chemotherapy, and operation on immunity function in middle or lower rectal cancer patients
|
Author keywords
Chemotherapy; Immunity, cellular; Radiotherapy; Rectal neoplasms
|
Indexed keywords
CAPECITABINE;
CD3 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
ADULT;
ARTICLE;
BLOOD SAMPLING;
CANCER CHEMOTHERAPY;
CANCER LOCALIZATION;
CANCER RADIOTHERAPY;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELLULAR IMMUNITY;
CONTROLLED STUDY;
FEMALE;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
MULTIPLE CYCLE TREATMENT;
NATURAL KILLER CELL;
OUTCOME ASSESSMENT;
POSTOPERATIVE PERIOD;
PREOPERATIVE CARE;
RADIATION DOSE FRACTIONATION;
RECTUM CANCER;
RECTUM SURGERY;
SINGLE DRUG DOSE;
ADULT;
AGED;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
IMMUNITY, CELLULAR;
KILLER CELLS, NATURAL;
MALE;
MIDDLE AGED;
RADIOTHERAPY, ADJUVANT;
RECTAL NEOPLASMS;
|
EID: 56349132817
PISSN: 03762491
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (12)
|